← Leaderboards
Michael F Holick
Boston University Medical Campus
$3,908,646
Attributed
$3,908,646
Total exposure
23
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $664.9K · FY2005–08$1M$750K$500K$250K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$3,908,646 · 23
By mechanism
R01$2,020,503 · 2
M01$850,651 · 17
R42$571,556 · 1
R41$254,304 · 1
R43$153,126 · 1
P41$58,506 · 1
Top collaborators
No co-investigators on record.
Most similar at Boston University Medical Campus
Same institution · by research overlap
- M Carter Cornwall$8,297,198
- Vladimir A Botchkarev$10,578,501
- Julie R Palmer$31,282,207
- Michael C Nevitt$34,596,835
- Shuyang Chen$1,437,201
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectTopical Drug ApplicationSkin Disorder ChemotherapyHuman Therapy EvaluationPsoriasis1,25 DihydroxycholecalciferolVitamin DTissue /Cell CultureOsteoporosisPhotobiologyHigh Performance Liquid ChromatographyMixed Tissue /Cell CultureKeratinocyteVitamin TherapyOutcomes ResearchParathyroid HormonesSteroid Hormone BiosynthesisMass SpectrometryStereochemistrySteroid Hormone MetabolismDrug Screening /EvaluationPhotostimulusChemical Kinetics
Grant awards (32)
GENERAL CLINICAL RESEARCH CENTER$1
M01 · FY2008 · RR · contact PI
PREVALENCE OF VITAMIN D DEFICIENCY IN PATIENTS ADMITTED TO REHABILITATION UNIT$347
M01 · FY2007 · RR · contact PI
PTH (7-34) for Chemotherapy alopecia in Breast Cancer$254,304
R41 · FY2006 · CA · contact PI
BONE DENSITY IN AGING MEN OF DIVERSE RACE AND ETHNICITY$91,491
M01 · FY2006 · RR · contact PI
FLOOD LAMP ULTRAVIOLET RAYS AND VITAMIN D$88,017
M01 · FY2006 · RR · contact PI
EFFECTS OF ULTRAVIOLET IRRADIATION ON VITAMIN D AND CALCIUM$21,619
M01 · FY2006 · RR · contact PI
PREVALENCE OF VITAMIN D DEFICIENCY IN PATIENTS ADMITTED TO REHABILITATION UNIT$12,739
M01 · FY2006 · RR · contact PI
The Photobiology of Vitamin D$334,150
R01 · FY2005 · AR
BONE DENSITY IN AGING MEN OF DIVERSE RACE AND ETHNICITY$235,363
M01 · FY2005 · RR
ULTRAVIOLET IRRADIATION AND VITAMIN D, CALCIUM AND GENE EXPRESSION$78,454
M01 · FY2005 · RR
PREVALENCE OF VITAMIN D DEFICIENCY IN PATIENTS ADMITTED TO REHABILITATION UNIT$16,943
M01 · FY2005 · RR
The Photobiology of Vitamin D$383,050
R01 · FY2004 · AR
Bone Density in Aging Men of Diverse Race and Ethnicity$112,480
M01 · FY2004 · RR
Vitamin D and Bone Density in Tanners and Non-Tanners$69,079
M01 · FY2004 · RR
FGF23 Antibody in Adults/Children with Metabolic Bone Di$2,170
M01 · FY2004 · RR
The Photobiology of Vitamin D$383,050
R01 · FY2003 · AR
The Photobiology of Vitamin D$364,183
R01 · FY2002 · AR
PHOTOBIOLOGY OF VITAMIN D$53,566
P41 · FY2001 · RR
TIMED PHOSPHATE ADMINISTRATION ON BONE MARKERS, PARATHYROID HORMONE AND PHOSPHATE$0
M01 · FY2001 · RR
SAFETY AND EFFICACY OF TOPICAL 19 NOR 1,25 DIHYDROXYVITAMIN D3 FOR PSORIASIS$0
M01 · FY2001 · RR
VITAMIN D3 FOR PSORIASIS$0
M01 · FY2001 · RR
THERAPY FOR CHEMOTHERAPY ALOPECIA WITH PTHRP ANALOGS$571,556
R42 · FY2000 · CA
PHOTOBIOLOGY OF VITAMIN D$315,870
R01 · FY2000 · AR
NEW BIOLOGIC FUNCTIONS OF PTHRP$240,200
R01 · FY2000 · DK
TREATMENT OF PSORIASIS WITH PARATHYROID HORMONE (1-34)$153,126
R43 · FY2000 · AR
TOPICAL HEXA-FLUORO 1,25-DIHYDROVITAMIN D3 IN TREATING PSORIASIS$30,487
M01 · FY2000 · RR
VITAMIN D3 FOR PSORIASIS$30,487
M01 · FY2000 · RR
TOPICAL 1,25 VITAMIN D3 IN CHILDREN WITH PSORIASIS$30,487
M01 · FY2000 · RR
HEXAFLUORO 1 ALPHA 25 DIHYDROXYVITAMIN D3 &DOVONEX FOR TREATING PSORIASIS$30,487
M01 · FY2000 · RR
PHOTOBIOLOGY OF VITAMIN D$4,940
P41 · FY2000 · RR
TIMED PHOSPHATE ADMI--BONE MARKERS, PTH IN OSTEOPOROSIS$0
M01 · FY2000 · RR
SAFETY / EFFICACY OF TOPICAL 19 NOR 1,25 DIHYDROXYVITAMIN D3 FOR PSORIASIS$0
M01 · FY2000 · RR